Personalized injectional carboxytherapy for patients with early complications after low-temperature hardware cosmetic procedures

Abstract

We conducted a clinical and instrumental examination in 62 patients diagnosed with E65 — localized fat deposition at the age of 28–42 years and body mass index (BMI) — 26–27, who received the cryolipolysis procedure (hardware non-surgical correction of local fat deposits) the day before on the infraumbilical area of the abdomen in order to correct local fat deposits. After 1–2 days, the patients began to complain of pronounced local edema and a change in sensitivity at the site of exposure to cryopressure. All patients underwent genetic testing on the Cosmetology panel before the start of treatment. When comparing the control and comparison groups, it was found that the use of an extended method of injectable carboxytherapy in the second comparison group with a high risk of inflammation and «weakness» of the vascular wall significantly improves the quality of life in terms of the dermatology life quality index (DLQI) compared to the first comparison group and the control groups. Edema decreases clinically, which correlates with a significant decrease in intradermal edema and dermal thickness in the first comparison group compared to the second comparison group and in the control group according to ultrasound examination with a 30 MHz sensor. Personalized injectional carboxytherapy is an effective factor in relieving complications after cryolipolysis.